Adenosine Injection, Solution
Product Images NDC 51662-1643

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Adenosine (NDC 51662-1643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (51662 1643 Table 1)

A data table listing units of sale, strengths, and packaging types for ADENOSINE injection. It shows three entries with NDCs 51662-1643-1, 51662-1643-2, and 51662-1643-3, each with a strength of 12 mg per 4 mL (3 mg per mL) in a 5 mL plastic prefilled syringe. Packaging includes single syringes, pouches, and cases of 10 syringes.*

FDA Label Image

Structure (51662 1643 Structure)

Chemical structure of Adenosine depicting its molecular arrangement with labeled nitrogen, hydrogen, oxygen atoms, and functional groups consistent with the purine nucleoside structure.*

FDA Label Image

Rfid Label (51662 1643 1 Syringe)

This is a label for ADENOSINE Injection, solution with a concentration of 3 mg/mL. It includes numeric codes, a QR code, and text instructing to see the manufacturer's insert. Distributed by HF Acquisition Co., LLC, Mukilteo, WA 98275. The label is marked RX ONLY.*

FDA Label Image

Pouch Label (51662 1643 2 Pouch)

Label for ADENOSINE injection, USP 3 mg/mL in a 4 mL syringe, providing a total of 12 mg per syringe. The label indicates sterile, preservative-free solution for rapid intravenous bolus use, manufactured by HF Acquisition Co., LLC in Mukilteo, WA. It includes the NDC number 51662-1643 and lot and expiration details.*

FDA Label Image

Case Label (51662 1643 3 Case Label)

Label for ADENOSINE Injection, USP 12 mg per 4 mL (3 mg/mL) solution for intravenous use in a 4 mL syringe. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA. The label includes NDC 51662-1643-3, lot number, expiration date, and storage instructions, indicating the solution is preservative-free and should be stored at 20 to 25°C without refrigeration.*

FDA Label Image

Rfid Label (51662 1643 3 Rfid)

Label for ADENOSINE injection, solution 3 mg/mL, distributed by HF Acquisitions Co, LLC, Mukilteo, WA. The label includes multiple identification barcodes and numeric codes, along with instructions to see the manufacturer's insert for further information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.